Indivior PLC Ordinary Shares share price logo

Indivior PLC Ordinary Shares Share Price

NASDAQ: INDV

Mid Cap

$32.97

+1.37

(+4.34%)

as on

Indivior PLC Ordinary Shares Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $31.66
    $32.96
    downward going graph

    3.97%

    Downside

    -0.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.69
    $38.00
    downward going graph

    73.64%

    Downside

    15.26%

    Upside

    downward going graph

Indivior PLC Ordinary Shares share price movements today

Previous Close
$31.60
Open
$31.73
Volume
798.6K
Day's Low - High
$31.66 - $32.96
52 Week Low - High
$8.69 - $38.00

Indivior PLC Ordinary Shares Historical Returns

1 Month Return
+ 1.58 %
3 Month Return
-6.04 %
1 Year Return
+ 234.75 %
3 Year Return
0 %
5 Year Return
0 %

Indivior PLC Ordinary Shares Stock Fundamentals & Key Indicators

Check Indivior PLC Ordinary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8B

EPS (TTM)

3.1214

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

3.76%

PE Ratio (TTM)

18.62

Industry PE ratio

16.77

PEG Ratio

0

EBITDA

397.0M

Revenue (TTM)

1.2B

Profit Margin

16.95%

Return On Equity TTM

12.20%

Indivior PLC Ordinary Shares Stock Valuation

Track how Indivior PLC Ordinary Shares P/E has moved over time to understand its valuation trends.

Indivior PLC Ordinary Shares in the last 5 years

  • Overview

  • Trends

Lowest (-144.69x)

December 31, 2024

Industry (16.77x)

April 14, 2026

Today (18.62x)

April 14, 2026

Highest (89.45x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 18.62x

Indivior PLC Ordinary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indivior PLC Ordinary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Indivior PLC Ordinary Shares image
Indivior PLC Ordinary Shares
BUY$3.8BNA18.6216.95%
Regencell Bioscience Holdings Ltd image
Regencell Bioscience Holdings Ltd
NA$14.3BNANA0.00%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.3BNA20.7541.94%
Viatris Inc image
Viatris Inc
HOLD$15.7B4.69%NA-24.58%
Haleon plc image
Haleon plc
BUY$43.9BNA19.6815.11%
See all

Stock Returns calculator for Indivior PLC Ordinary Shares Stock including INR - Dollar returns

The Indivior PLC Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Indivior PLC Ordinary Shares investment value today

Current value as on today

₹3,77,806

Returns

₹2,77,806

(+277.81%)

Returns from Indivior PLC Ordinary Shares Stock

₹2,49,258 (+249.26%)

Dollar Impact

₹28,548 (+28.55%)

Analyst Recommendation on Indivior PLC Ordinary Shares Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Indivior PLC Ordinary Shares. Average target price of $46.86

Indivior PLC Ordinary Shares Share Price Target

Get share price movements and forecasts by analysts on Indivior PLC Ordinary Shares.

What analysts predicted

29.64%UPSIDE

Target Price

$46.86

Current Price

$32.97

Analyzed by

7 Analysts

Target

$46.86

Indivior PLC Ordinary Shares target price $46.86, a slight upside of 29.64% compared to current price of $32.97. According to 7 analysts rating.

Indivior PLC Ordinary Shares Stock’s Investor Sentiment and Interest

Search interest for Indivior PLC Ordinary Shares Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

Indivior PLC Ordinary Shares Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
271
293
284
299
307
299
266
302
314
358
Gross Profit
225
242
246
220
238
276
222
250
230
294
Operating Income
-183
61
75
-118
4
96
66
72
43
122
EBITDA
-164
79
87
-106
22
106
76
82
51
92
Interest Expense
10
9
8
9
10
13
12
15
12
6
Depreciation
7
9
9
25
-10
5
5
5
5
5
Income Before Tax
-181
62
73
-121
-1
88
59
62
37
81
Income Tax Expense
-46
8
11
-23
-5
28
11
44
-5
-21
Net Income
-135
54
61
-97
4
59
47
18
42
103
Net Profit Margin
-49.82%
18.43%
21.48%
-32.44%
1.30%
19.73%
17.67%
5.96%
13.38%
28.77%

Indivior PLC Ordinary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
968
1,148
959
785
647
791
901
1,093
1,188
1,239
Gross Profit
858
1,025
825
645
550
664
750
919
957
994
Operating Income
337
423
317
178
-156
213
-81
-156
32
262
EBITDA
149
436
310
230
-123
238
-46
-99
84
304
Interest Expense
51
49
31
22
24
26
29
35
41
45
Depreciation
-
-
-
28
26
22
21
28
29
20
Income Before Tax
89
143
265
180
-173
190
-89
-149
14
239
Income Tax Expense
57
82
2
46
-25
-15
-44
-20
11
29
Net Income
32
60
262
134
-148
205
-44
-129
2
210
Net Profit Margin
3.31%
5.31%
27.36%
17.07%
-22.87%
25.92%
-4.88%
-11.80%
0.17%
16.95%

Indivior PLC Ordinary Shares Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
54
46
-107
3
20
47
18
43
102
Operating Cash Flow
-279
-54
87
8
-5
75
166
-39
-221
Investing Cash Flow
8
24
1
32
9
-5
-18
-20
-24
Financing Cash Flow
-20
-37
-34
-55
29
-17
-4
-3
-5
Change in Cash
-294
-67
54
-14
31
53
138
-65
-250

Indivior PLC Ordinary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
60
262
178
-156
213
-44
-129
2
210
Operating Cash Flow
309
289
151
-193
353
-4
-300
36
-27
Investing Cash Flow
-45
-3
-2
-4
-14
-222
-95
69
-66
Financing Cash Flow
-88
-226
-13
-10
-94
-101
-64
-102
-30
Change in Cash
171
60
136
-202
244
-328
-458
3
-124

Indivior PLC Ordinary Shares News & Key Events

    Insights on Indivior PLC Ordinary Shares

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 year, INDV stock has moved up by 234.7%

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 3 quarters, 18.0M → 103.0M (in $), with an average increase of 58.2% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 4 quarters, 266.0M → 358.0M (in $), with an average increase of 9.3% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regencell Bioscience Holdings Ltd has given 3653.6% return, outperforming this stock by 3418.9%

    About Indivior PLC Ordinary Shares

    Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
    OrganisationIndivior PLC Ordinary Shares
    Headquarters10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235
    IndustryDrug Manufacturers - Specialty & Generic
    CEOMr. Joseph J. Ciaffoni
    E-voting on sharesClick here to vote

    Key Management of Indivior PLC Ordinary Shares

    Name

    Title

    Mr. Joseph J. Ciaffoni

    CEO & Director

    Mr. Ryan Preblick

    Chief Financial Officer

    Dr. Christian Heidbreder

    Chief Scientific Officer

    Ms. Alice G. Givens

    Company Secretary

    Mr. Jeffrey W. Burris J.D.

    Chief Legal Officer

    Mr. Patrick a. Barry

    Chief Commercial Officer

    Mr. Jason Thompson

    Vice President of Investor Relations

    Mr. Kevin L. Espinoza

    Chief Integrity & Compliance Officer

    Ms. Angela Colon-Mahoney M.S.

    Chief Human Resources Officer

    Ms. Vanessa Procter

    Executive Vice President of Corporate Affairs

    FAQs

    What is Indivior PLC Ordinary Shares share price today?

    Indivior PLC Ordinary Shares share price today is $32.97 as on at the close of the market. Indivior PLC Ordinary Shares share today touched a day high of $32.96 and a low of $31.66.

    What is the 52 week high and 52 week low for Indivior PLC Ordinary Shares share?

    Indivior PLC Ordinary Shares share touched a 52 week high of $38 on and a 52 week low of $8.69 on . Indivior PLC Ordinary Shares stock price today i.e. is closed at $32.97,which is 13.24% down from its 52 week high and 279.40% up from its 52 week low.

    What is Indivior PLC Ordinary Shares's market capitalisation today?

    Indivior PLC Ordinary Shares market capitalisation is $0.00T as on .

    How to invest in Indivior PLC Ordinary Shares Stock (INDV) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Indivior PLC Ordinary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indivior PLC Ordinary Shares Shares that will get you 0.0455 shares as per Indivior PLC Ordinary Shares share price of $32.97 per share as on April 15, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Indivior PLC Ordinary Shares Stock (INDV) from India?

    Indian investors can start investing in Indivior PLC Ordinary Shares (INDV) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹930.82 in Indivior PLC Ordinary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Indivior PLC Ordinary Shares share’s latest price of $32.97 as on April 15, 2026 at 1:29 am IST, you will get 0.3033 shares of Indivior PLC Ordinary Shares. Learn more about fractional shares .